Brief: Gufic Biosciences Seeks Shareholders' Nod For Scheme Of Amalgamation Of Gufic Stridden Bio-Pharma
27/04/2018 10:30
April 27 (Reuters) - Gufic Biosciences Ltd GUFI.NS :
* SEEKS SHAREHOLDERS' NOD FOR SCHEME OF AMALGAMATION OF
GUFIC
STRIDDEN BIO-PHARMA PRIVATE LIMITED WITH CO
Source text - http://bit.ly/2I3evPa
Further company coverage: GUFI.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gufic Biosciences
See all newsBrief: Gufic Biosciences Says USFDA Pre-Approval Inspection At Indore Facility
Brief: Gufic Biosciences June-Quarter Consol Total Profit 223.1 Million Rupees
Brief: Gufic Biosciences Receives Tax Demand Notice For 43.3 Million Rupees
Brief: Gufic Biosciences Receives Tax Demand Notice For 43.3 Million Rupees
Brief: Gufic Biosciences posts Sept-Quarter Consol Revenue From Operations 2.37 Billion Rupees